Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lazanda for breakthrough cancer pain
NCT01839552Phase 4Withdrawn
- Sponsor
- University of Louisville
- Start
- Oct 2014
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fentanyl in breakthrough pain, sponsored by University of Louisville. Planned start Oct 2014; status: withdrawn.
02
Drugs
fentanyl
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT01839552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01839552.